(19)
(11) EP 2 891 663 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.04.2018 Bulletin 2018/14

(45) Mention of the grant of the patent:
20.12.2017 Bulletin 2017/51

(21) Application number: 13833212.7

(22) Date of filing: 29.08.2013
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
A61K 39/00(2006.01)
A61P 35/00(2006.01)
C07K 7/06(2006.01)
 A61K 38/00(2006.01)
A61K 48/00(2006.01)
A61P 43/00(2006.01)
C12N 15/09(2006.01)
(86) International application number:
PCT/JP2013/073084
(87) International publication number:
WO 2014/034754 (06.03.2014 Gazette 2014/10)

(54)

PSF1-DERIVED PEPTIDE

PSF1-ABGELEITETE PEPTIDE

PEPTIDE DÉRIVÉ DE PSF1

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.08.2012 JP 2012191050

(43) Date of publication of application:
08.07.2015 Bulletin 2015/28

(73) Proprietor: Vasculead Inc.
Osaka-shi, Osaka 556-0005 (JP)

(72) Inventors:
  • TANAKA, Hidekazu
    Toyonaka-shi Osaka 561-0825 (JP)
  • IGUCHI, Motofumi
    Toyonaka-shi Osaka 561-0825 (JP)
  • YOKOYAMA, Mari
    Toyonaka-shi Osaka 561-0825 (JP)

(74) Representative: Schiweck, Weinzierl & Koch Patentanwälte Partnerschaft mbB 
Landsberger Straße 98
80339 München
80339 München (DE)


(56) References cited: : 
WO-A1-2007/119515
WO-A2-03/033675
 WO-A1-2008/102557
   
  • NAKAHARA IZUMI ET AL: "Up-regulation of PSF1 promotes the growth of breast cancer cells", GENES TO CELLS, vol. 15, no. 10, October 2010 (2010-10), pages 1015-1024, XP55196485, ISSN: 1356-9597
  • NAKAHARA, I. ET AL.: 'Up-regulation of PSF1 promotes the growth of breast cancer cells' GENES TO CELLS vol. 15, 2010, pages 1015 - 1024, XP055196485
  • IZUMI NAKAHARA ET AL.: 'PSF1 Idenshi no Kajo Hatsugen wa Nyugan Saibo no Zoshoku o Sokushin suru' 32ND ANNUAL MEETING OF THE MOLECULAR BIOLOGY SOCIETY OF JAPAN YOSHISHU 2009, page 1P-0755, XP008176884
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).